Insider filing · ADCT

Jeremy Green bought $609K of ADC Therapeutics SA (ADCT)

Executed Dec 11 2024, disclosed Dec 13 2024, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Dec 13 2024), the stock returned -11.0% (delay-adjusted); from the execution session (Dec 11 2024), -49.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

JG Jeremy Green Director profile →

Jeremy Green (Director) filed 3 Form 4 reports in the past 24 months (3 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in ADCT. Across 3 priced purchase filings, the average 21-session return was -17.6% from execution and -11.5% from disclosure (delay-adjusted; derived). The largest single filing was $669K of FATE (397,964 sh × $1.68, as filed), executed Dec 20 2024.

ADCT ADCT ADCT · 2 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→